首页>
外国专利>
MONO AND COMBINATION THERAPY WITH M1/M4 MUSCARINIC AGONIST (SABCOMELINE) FOR TREATMENT OF PRODROMAL SYNDROME
MONO AND COMBINATION THERAPY WITH M1/M4 MUSCARINIC AGONIST (SABCOMELINE) FOR TREATMENT OF PRODROMAL SYNDROME
展开▼
机译:M1 / M4肌肉促肌药(SABCOMELINE)的单核和联合疗法治疗前驱综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof to treat prodromal syndrome and in the manufacture of a medicament for the treatment of prodromal syndrome, and to a method of treatment of prodromal syndrome using a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof. It also relates to the use of a pharmaceutical composition comprising a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof, and at least one cholinergic agent and/or at least one non-cholinergic agent for the treatment of prodromal syndrome, and to a method of treatment of prodromal syndrome by administration of a such a pharmaceutical composition.
展开▼